Sponsor intelligence · OTHER
Clinical trials sponsored by
Fudan University.
Real, source-linked trial activity for Fudan University: 21 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE2 10NA 5N/A 3PHASE3 3
Newest Fudan University trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 3d ago | Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and B | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 3d ago | Chemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- B | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 3d ago | The Role of Total Abdominal Autonomic Nerve Preservation During the Re | N/A | ACTIVE_NOT_RECRUITING | ↗ |
| 4d ago | Consolidative Stereotactic Radiotherapy for Oligo-Residual Advanced EG | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 6d ago | Clinical Value of CT Perfusion in Peripheral Artery Disease | N/A | NOT_YET_RECRUITING | ↗ |
| 6d ago | MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced No | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 9d ago | PBI for Low-risk Breast Cancer | NA | RECRUITING | ↗ |
| 9d ago | FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy fo | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 16d ago | AI-Assisted Patient Support in mHSPC | NA | NOT_YET_RECRUITING | ↗ |
| 16d ago | Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neo | NA | RECRUITING | ↗ |
| 24d ago | Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for N | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 25d ago | Metformin in Elderly Patients With Type 2 Diabetes and Muscle Strength | N/A | COMPLETED | ↗ |
| 26d ago | APEX-STROKE Adaptive Platform Trial for Stroke | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 27d ago | Response-adapted Postoperative Radiotherapy In Locally Advanced Head a | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 30d ago | The Study Of Andamertinib Plus Anlotinib In Patients With Locally Adva | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 31d ago | Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in Br | NA | RECRUITING | ↗ |
| 33d ago | Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Brea | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 34d ago | GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 39d ago | An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan Wit | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 40d ago | The Necessity of Surgery in Patients With mGC Achieving Radiological R | Ph 2 | RECRUITING | ↗ |
| 55d ago | AI-Guided TURBT for Bladder Cancer | NA | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Fudan University (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.